drugset

drugset / Trial / NCT06361927

A Phase II Study of SSGJ-707 Monotherapy in First-line PD-L1 Positive Advanced NSCLC Patients

NCT06361927 ↗

Phase 2 Unknown 120 enrolled Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study includes two cohorts, cohort A is for non-squamous NSCLC and cohort B is for squamous NSCLC.

Timeline

Start: 2024-05-15
Primary completion: 2025-06
Completion: 2025-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	PF-08634404	Unknown	—	—

Indications